C8957 |
 |
Intravenous infusion for therapy/diagnosis; initiation of prolonged infusion (more than 8 hours), requiring use of portable or implantable pump
short | Prolonged iv inf, req pump |
MUE | Location | Value | Ajudication Indicator | Rationale |
---|
PRA | 2.0 | 3 Date of Service Edit: Clinical | CMS Policy | OPH | 2.0 | 3 Date of Service Edit: Clinical | CMS Policy |
|
|
|
C9014 |
 |
Injection, cerliponase alfa, 1 mg
short | Injection, cerliponase alfa |
|
|
C9015 |
 |
Injection, c-1 esterase inhibitor (human), haegarda, 10 units
short | C-1 esterase, haegarda |
|
|
C9016 |
 |
Injection, triptorelin extended release, 3.75 mg
short | Inj, triptorelin ext rel |
|
|
C9021 |
 |
Injection, obinutuzumab, 10 mg
short | Injection, obinutuzumab |
|
|
C9022 |
 |
Injection, elosulfase alfa, 1mg
short | Injection, elosulfase alfa |
|
|
C9023 |
 |
Injection, testosterone undecanoate, 1 mg
short | Inj testosterone undecanoate |
|
|
C9024 |
 |
Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine
short | Inj, daunorubicin-cytarabine |
|
|
C9025 |
 |
Injection, ramucirumab, 5 mg
short | Injection, ramucirumab |
|
|
C9026 |
 |
Injection, vedolizumab, 1 mg
short | Injection, vedolizumab |
|
|
C9027 |
 |
Injection, pembrolizumab, 1 mg
short | Injection, pembrolizumab |
|
|
C9028 |
 |
Injection, inotuzumab ozogamicin, 0.1 mg
short | Inj. inotuzumab ozogamicin |
|
|
C9029 |
 |
Injection, guselkumab, 1 mg
short | Injection, guselkumab |
|
|
C9030 |
 |
Injection, copanlisib, 1 mg
|
|
C9031 |
 |
Lutetium lu 177, dotatate, therapeutic, 1 mci
short | Lutetium lu 177 dotatate, tx |
|
|
C9032 |
 |
Injection, voretigene neparvovec-rzyl, 1 billion vector genome
short | Voretigene neparvovec-rzyl |
|
|
C9033 |
 |
Injection, fosnetupitant 235 mg and palonosetron 0.25 mg
|
|
C9034 |
 |
Injection, dexamethasone 9%, intraocular, 1 mcg
short | Injection, dexamethasone 9% |
|
|
C9035 |
 |
Injection, aripiprazole lauroxil (aristada initio), 1 mg
short | Injection, aristada initio |
|
|
C9036 |
 |
Injection, patisiran, 0.1 mg
short | Injection, patisiran |
|
|
C9037 |
 |
Injection, risperidone (perseris), 0.5 mg
short | Injection, risperidone |
|
|
C9038 |
 |
Injection, mogamulizumab-kpkc, 1 mg
short | Inj mogamulizumab-kpkc |
|
|
C9039 |
 |
Injection, plazomicin, 5 mg
short | Injection, plazomicin |
|
|
C9040 |
 |
Injection, fremanezumab-vfrm, 1mg
short | Injection, fremanezumab-vfrm |
|
|
C9041 |
 |
Injection, coagulation factor xa (recombinant), inactivated (andexxa), 10 mg
short | Inj, coagulation factor xa |
MUE | Location | Value | Ajudication Indicator | Rationale |
---|
PRA | 180.0 | 3 Date of Service Edit: Clinical | CMS Policy | OPH | 180.0 | 3 Date of Service Edit: Clinical | CMS Policy |
|
|
|
C9042 |
 |
Injection, bendamustine hcl (belrapzo), 1 mg
|
|
C9043 |
 |
Injection, levoleucovorin, 1 mg
short | Injection, levoleucovorin |
|
|
C9044 |
 |
Injection, cemiplimab-rwlc, 1 mg
short | Injection, cemiplimab-rwlc |
|
|
C9045 |
 |
Injection, moxetumomab pasudotox-tdfk, 0.01 mg
short | Moxetumomab pasudotox-tdfk |
|
|
C9046 |
 |
Cocaine hydrochloride nasal solution for topical administration, 1 mg
short | Cocaine hcl nasal solution |
MUE | Location | Value | Ajudication Indicator | Rationale |
---|
PRA | 160.0 | 3 Date of Service Edit: Clinical | Prescribing Information | OPH | 160.0 | 3 Date of Service Edit: Clinical | Prescribing Information |
|
|
|
C9047 |
 |
Injection, caplacizumab-yhdp, 1 mg
short | Injection, caplacizumab-yhdp |
|
|
C9048 |
 |
Dexamethasone, lacrimal ophthalmic insert, 0.1 mg
short | Dexamethasone ophth insert |
|
|
C9049 |
 |
Injection, tagraxofusp-erzs, 10 mcg
short | Injection, tagraxofusp-erzs |
|
|
C9050 |
 |
Injection, emapalumab-lzsg, 1 mg
short | Injection, emapalumab-lzsg |
|
|
C9051 |
 |
Injection, omadacycline, 1 mg
short | Injection, omadacycline |
|
|
C9052 |
 |
Injection, ravulizumab-cwvz, 10 mg
short | Injection, ravulizumab-cwv |
|
|
C9054 |
 |
Injection, lefamulin (xenleta), 1 mg
short | Injection, lefamulin |
|
|
C9055 |
 |
Injection, brexanolone, 1mg
|
|
C9113 |
 |
Injection, pantoprazole sodium, per vial
short | Inj pantoprazole sodium, via |
MUE | Location | Value | Ajudication Indicator | Rationale |
---|
PRA | 10.0 | 3 Date of Service Edit: Clinical | Clinical: CMS Workgroup | OPH | 10.0 | 3 Date of Service Edit: Clinical | Clinical: Data |
|
|
|
C9121 |
 |
Injection, argatroban, per 5 mg
short | Injection, argatroban |
|
|
C9132 |
 |
Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activity
short | Kcentra, per i.u. |
MUE | Location | Value | Ajudication Indicator | Rationale |
---|
PRA | 5500.0 | 3 Date of Service Edit: Clinical | Prescribing Information | OPH | 5500.0 | 3 Date of Service Edit: Clinical | Prescribing Information |
|
|
|
C9133 |
 |
Factor ix (antihemophilic factor, recombinant), rixubis, per i.u.
short | Factor ix recombinant |
|
|
C9134 |
 |
Factor xiii (antihemophilic factor, recombinant), tretten, per 10 i.u.
short | Factor xiii a-subunit recomb |
|
|
C9135 |
 |
Factor ix (antihemophilic factor, recombinant), alprolix, per i.u.
short | Factor ix (alprolix) |
|
|
C9136 |
 |
Injection, factor viii, fc fusion protein, (recombinant), per i.u.
short | Factor viii (eloctate) |
|
|
C9137 |
 |
Injection, factor viii (antihemophilic factor, recombinant) pegylated, 1 i.u.
short | Adynovate factor viii recom |
|
|
C9138 |
 |
Injection, factor viii (antihemophilic factor, recombinant) (nuwiq), 1 i.u.
short | Nuwiq factor viii recomb |
|
|
C9139 |
 |
Injection, factor ix, albumin fusion protein (recombinant), idelvion, 1 i.u.
|
|
C9140 |
 |
Injection, factor viii (antihemophilic factor, recombinant) (afstyla), 1 i.u.
short | Afstyla factor viii recomb |
|
|
C9141 |
 |
Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl (jivi), 1 i.u.
short | Factor viii pegylated-aucl |
|
|
C9248 |
 |
Injection, clevidipine butyrate, 1 mg
short | Inj, clevidipine butyrate |
MUE | Location | Value | Ajudication Indicator | Rationale |
---|
PRA | 25.0 | 3 Date of Service Edit: Clinical | Clinical: CMS Workgroup | OPH | 25.0 | 3 Date of Service Edit: Clinical | Clinical: Data |
|
|
|
C9250 |
 |
Human plasma fibrin sealant, vapor-heated, solvent-detergent (artiss), 2 ml
short | Artiss fibrin sealant |
MUE | Location | Value | Ajudication Indicator | Rationale |
---|
PRA | 1.0 | 3 Date of Service Edit: Clinical | Clinical: Data | OPH | 5.0 | 3 Date of Service Edit: Clinical | Clinical: Data |
|
|
|
C9254 |
 |
Injection, lacosamide, 1 mg
short | Injection, lacosamide |
MUE | Location | Value | Ajudication Indicator | Rationale |
---|
PRA | 400.0 | 3 Date of Service Edit: Clinical | Clinical: CMS Workgroup | OPH | 400.0 | 3 Date of Service Edit: Clinical | Prescribing Information |
|
|
|
C9257 |
 |
Injection, bevacizumab, 0.25 mg
short | Bevacizumab injection |
MUE | Location | Value | Ajudication Indicator | Rationale |
---|
PRA | 5.0 | 3 Date of Service Edit: Clinical | Prescribing Information | OPH | 8000.0 | 3 Date of Service Edit: Clinical | Clinical: Data |
|
|
|
C9275 |
 |
Injection, hexaminolevulinate hydrochloride, 100 mg, per study dose
short | Hexaminolevulinate hcl |
|
|
C9285 |
 |
Lidocaine 70 mg/tetracaine 70 mg, per patch
short | Patch, lidocaine/tetracaine |
MUE | Location | Value | Ajudication Indicator | Rationale |
---|
PRA | 2.0 | 3 Date of Service Edit: Clinical | Prescribing Information | OPH | 2.0 | 3 Date of Service Edit: Clinical | Prescribing Information |
|
|
|
C9290 |
 |
Injection, bupivacaine liposome, 1 mg
short | Inj, bupivacaine liposome |
MUE | Location | Value | Ajudication Indicator | Rationale |
---|
PRA | 266.0 | 3 Date of Service Edit: Clinical | Prescribing Information | OPH | 266.0 | 3 Date of Service Edit: Clinical | Prescribing Information |
|
|
|
C9293 |
 |
Injection, glucarpidase, 10 units
short | Injection, glucarpidase |
MUE | Location | Value | Ajudication Indicator | Rationale |
---|
PRA | 700.0 | 3 Date of Service Edit: Clinical | Prescribing Information | OPH | 700.0 | 3 Date of Service Edit: Clinical | Prescribing Information |
|
|
|
C9349 |
 |
Puraply, and puraply antimicrobial, any type, per square centimeter
short | Puraply, puraply antimic |
|
|
C9352 |
 |
Microporous collagen implantable tube (neuragen nerve guide), per centimeter length
short | Neuragen nerve guide, per cm |
MUE | Location | Value | Ajudication Indicator | Rationale |
---|
PRA | 3.0 | 3 Date of Service Edit: Clinical | Prescribing Information | OPH | 3.0 | 3 Date of Service Edit: Clinical | Prescribing Information |
|
|
|
C9353 |
 |
Microporous collagen implantable slit tube (neurawrap nerve protector), per centimeter length
short | Neurawrap nerve protector,cm |
MUE | Location | Value | Ajudication Indicator | Rationale |
---|
PRA | 4.0 | 3 Date of Service Edit: Clinical | Prescribing Information | OPH | 4.0 | 3 Date of Service Edit: Clinical | Prescribing Information |
|
|
|
C9354 |
 |
Acellular pericardial tissue matrix of non-human origin (veritas), per square centimeter
short | Veritas collagen matrix, cm2 |
MUE | Location | Value | Ajudication Indicator | Rationale |
---|
PRA | 300.0 | 3 Date of Service Edit: Clinical | Prescribing Information | OPH | 300.0 | 3 Date of Service Edit: Clinical | Prescribing Information |
|
|
|
C9355 |
 |
Collagen nerve cuff (neuromatrix), per 0.5 centimeter length
short | Neuromatrix nerve cuff, cm |
MUE | Location | Value | Ajudication Indicator | Rationale |
---|
PRA | 3.0 | 3 Date of Service Edit: Clinical | Prescribing Information | OPH | 3.0 | 3 Date of Service Edit: Clinical | Prescribing Information |
|
|
|
C9356 |
 |
Tendon, porous matrix of cross-linked collagen and glycosaminoglycan matrix (tenoglide tendon protector sheet), per square centimeter
short | Tenoglide tendon prot, cm2 |
MUE | Location | Value | Ajudication Indicator | Rationale |
---|
PRA | 125.0 | 3 Date of Service Edit: Clinical | Prescribing Information | OPH | 125.0 | 3 Date of Service Edit: Clinical | Prescribing Information |
|
|
|
C9358 |
 |
Dermal substitute, native, non-denatured collagen, fetal bovine origin (surgimend collagen matrix), per 0.5 square centimeters
short | Surgimend, fetal |
MUE | Location | Value | Ajudication Indicator | Rationale |
---|
PRA | 800.0 | 3 Date of Service Edit: Clinical | Clinical: Data | OPH | 800.0 | 3 Date of Service Edit: Clinical | Clinical: Data |
|
|
|
C9359 |
 |
Porous purified collagen matrix bone void filler (integra mozaik osteoconductive scaffold putty, integra os osteoconductive scaffold putty), per 0.5 cc
short | Implnt,bon void filler-putty |
MUE | Location | Value | Ajudication Indicator | Rationale |
---|
PRA | 30.0 | 3 Date of Service Edit: Clinical | Prescribing Information | OPH | 30.0 | 3 Date of Service Edit: Clinical | Prescribing Information |
|
|
|
C9360 |
 |
Dermal substitute, native, non-denatured collagen, neonatal bovine origin (surgimend collagen matrix), per 0.5 square centimeters
short | Surgimend, neonatal |
MUE | Location | Value | Ajudication Indicator | Rationale |
---|
PRA | 300.0 | 3 Date of Service Edit: Clinical | Clinical: Data | OPH | 300.0 | 3 Date of Service Edit: Clinical | Clinical: Data |
|
|
|
C9361 |
 |
Collagen matrix nerve wrap (neuromend collagen nerve wrap), per 0.5 centimeter length
short | Neuromend nerve wrap |
MUE | Location | Value | Ajudication Indicator | Rationale |
---|
PRA | 10.0 | 3 Date of Service Edit: Clinical | Prescribing Information | OPH | 10.0 | 3 Date of Service Edit: Clinical | Prescribing Information |
|
|
|
C9362 |
 |
Porous purified collagen matrix bone void filler (integra mozaik osteoconductive scaffold strip), per 0.5 cc
short | Implnt,bon void filler-strip |
MUE | Location | Value | Ajudication Indicator | Rationale |
---|
PRA | 60.0 | 3 Date of Service Edit: Clinical | Clinical: Data | OPH | 60.0 | 3 Date of Service Edit: Clinical | Clinical: Data |
|
|
|
C9363 |
 |
Skin substitute, integra meshed bilayer wound matrix, per square centimeter
short | Integra meshed bil wound mat |
MUE | Location | Value | Ajudication Indicator | Rationale |
---|
PRA | 500.0 | 3 Date of Service Edit: Clinical | Clinical: Data | OPH | 500.0 | 3 Date of Service Edit: Clinical | Clinical: Data |
|
|
|
C9364 |
 |
Porcine implant, permacol, per square centimeter
short | Porcine implant, permacol |
MUE | Location | Value | Ajudication Indicator | Rationale |
---|
PRA | 600.0 | 3 Date of Service Edit: Clinical | Clinical: Data | OPH | 600.0 | 3 Date of Service Edit: Clinical | Clinical: Data |
|
|
|
C9399 |
 |
Unclassified drugs or biologicals
short | Unclassified drugs or biolog |
|
|
C9407 |
 |
Iodine i-131 iobenguane, diagnostic, 1 millicurie
short | Iodine i-131 iobenguane, dx |
|
|
C9408 |
 |
Iodine i-131 iobenguane, therapeutic, 1 millicurie
short | Iodine i-131 iobenguane, tx |
|
|
C9441 |
 |
Injection, ferric carboxymaltose, 1 mg
short | Inj, ferric carboxymaltose |
|
|
C9442 |
 |
Injection, belinostat, 10 mg
short | Injection, belinostat |
|
|
C9443 |
 |
Injection, dalbavancin, 10 mg
short | Injection, dalbavancin |
|
|
C9444 |
 |
Injection, oritavancin, 10 mg
short | Injection, oritavancin |
|
|
C9445 |
 |
Injection, c-1 esterase inhibitor (recombinant), ruconest, 10 units
short | C-1 esterase, ruconest |
|
|
C9446 |
 |
Injection, tedizolid phosphate, 1 mg
short | Inj, tedizolid phosphate |
|
|
C9447 |
 |
Injection, phenylephrine and ketorolac, 4 ml vial
short | Inj, phenylephrine ketorolac |
|
|
C9448 |
 |
Netupitant 300 mg and palonosetron 0.5 mg, oral
short | Oral netupitant palonosetron |
|
|
C9449 |
 |
Injection, blinatumomab, 1 mcg
|
|
C9450 |
 |
Injection, fluocinolone acetonide intravitreal implant, 0.01 mg
short | Fluocinolone acetonide implt |
|
|
C9451 |
 |
Injection, peramivir, 1 mg
short | Injection, peramivir |
|
|
C9452 |
 |
Injection, ceftolozane 50 mg and tazobactam 25 mg
short | Inj, ceftolozane/tazobactam |
|
|
C9453 |
 |
Injection, nivolumab, 1 mg
short | Injection, nivolumab |
|
|
C9454 |
 |
Injection, pasireotide long acting, 1 mg
short | Inj, pasireotide long acting |
|
|
C9455 |
 |
Injection, siltuximab, 10 mg
short | Injection, siltuximab |
|
|
C9456 |
 |
Injection, isavuconazonium sulfate, 1 mg
short | Inj, isavuconazonium sulfate |
|
|
C9457 |
 |
Injection, sulfur hexafluoride lipid microsphere, per ml
short | Lumason contrast agent |
|
|
C9458 |
 |
Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries
|
|
C9459 |
 |
Flutemetamol f18, diagnostic, per study dose, up to 5 millicuries
|
|
C9460 |
 |
Injection, cangrelor, 1 mg
short | Injection, cangrelor |
MUE | Location | Value | Ajudication Indicator | Rationale |
---|
PRA | 1.0 | 3 Date of Service Edit: Clinical | Clinical: CMS Workgroup | OPH | 100.0 | 3 Date of Service Edit: Clinical | Prescribing Information |
|
|
|
C9461 |
 |
Choline c 11, diagnostic, per study dose
short | Choline c 11, diagnostic |
|
|
C9462 |
 |
Injection, delafloxacin, 1 mg
short | Injection, delafloxacin |
MUE | Location | Value | Ajudication Indicator | Rationale |
---|
PRA | 600.0 | 3 Date of Service Edit: Clinical | Prescribing Information | OPH | 600.0 | 3 Date of Service Edit: Clinical | Prescribing Information |
|
|
|
C9463 |
 |
Injection, aprepitant, 1 mg
short | Injection, aprepitant |
|
|
C9464 |
 |
Injection, rolapitant, 0.5 mg
short | Injection, rolapitant |
|
|
C9465 |
 |
Hyaluronan or derivative, durolane, for intra-articular injection, per dose
|
|
C9466 |
 |
Injection, benralizumab, 1 mg
short | Injection, benralizumab |
|
|
C9467 |
 |
Injection, rituximab and hyaluronidase, 10 mg
short | Inj rituximab hyaluronidase |
|
|
C9468 |
 |
Injection, factor ix (antihemophilic factor, recombinant), glycopegylated, rebinyn, 1 i.u.
short | Inj, factor ix, rebinyn |
|
|
C9469 |
 |
Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg
short | Inj triamcinolone acetonide |
|
|
C9470 |
 |
Injection, aripiprazole lauroxil, 1 mg
short | Aripiprazole lauroxil im |
|
|
C9471 |
 |
Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg
|
|
C9472 |
 |
Injection, talimogene laherparepvec, 1 million plaque forming units (pfu)
short | Inj talimogene laherparepvec |
|
|
C9473 |
 |
Injection, mepolizumab, 1 mg
short | Injection, mepolizumab |
|
|
C9474 |
 |
Injection, irinotecan liposome, 1 mg
short | Inj, irinotecan liposome |
|
|
C9475 |
 |
Injection, necitumumab, 1 mg
short | Injection, necitumumab |
|
|
C9476 |
 |
Injection, daratumumab, 10 mg
short | Injection, daratumumab |
|
|
C9477 |
 |
Injection, elotuzumab, 1 mg
short | Injection, elotuzumab |
|
|
C9478 |
 |
Injection, sebelipase alfa, 1 mg
short | Injection, sebelipase alfa |
|
|
C9479 |
 |
Instillation, ciprofloxacin otic suspension, 6 mg
short | Instill, ciprofloxacin otic |
|
|
C9480 |
 |
Injection, trabectedin, 0.1 mg
short | Injection, trabectedin |
|
|
C9481 |
 |
Injection, reslizumab, 1 mg
short | Injection, reslizumab |
|
|
C9482 |
 |
Injection, sotalol hydrochloride, 1 mg
short | Sotalol hydrochloride iv |
MUE | Location | Value | Ajudication Indicator | Rationale |
---|
PRA | 150.0 | 3 Date of Service Edit: Clinical | Prescribing Information | OPH | 300.0 | 3 Date of Service Edit: Clinical | Prescribing Information |
|
|
|
C9483 |
 |
Injection, atezolizumab, 10 mg
short | Injection, atezolizumab |
|
|
C9484 |
 |
Injection, eteplirsen, 10 mg
short | Injection, eteplirsen |
|
|
C9485 |
 |
Injection, olaratumab, 10 mg
short | Injection, olaratumab |
|
|
C9486 |
 |
Injection, granisetron extended release, 0.1 mg
short | Inj, granisetron ext |
|
|
C9487 |
 |
Ustekinumab, for intravenous injection, 1 mg
short | Ustekinumab iv inj, 1 mg |
|
|
C9488 |
 |
Injection, conivaptan hydrochloride, 1 mg
short | Conivaptan hcl |
MUE | Location | Value | Ajudication Indicator | Rationale |
---|
PRA | 20.0 | 3 Date of Service Edit: Clinical | Prescribing Information | OPH | 40.0 | 3 Date of Service Edit: Clinical | Prescribing Information |
|
|
|
C9489 |
 |
Injection, nusinersen, 0.1 mg
short | Injection, nusinersen |
|
|
C9490 |
 |
Injection, bezlotoxumab, 10 mg
short | Injection, bezlotoxumab |
|
|
C9491 |
 |
Injection, avelumab, 10 mg
|
|
C9492 |
 |
Injection, durvalumab, 10 mg
short | Injection, durvalumab |
|
|
C9493 |
 |
Injection, edaravone, 1 mg
short | Injection, edaravone |
|
|
C9494 |
 |
Injection, ocrelizumab, 1 mg
short | Injection, ocrelizumab |
|
|
C9497 |
 |
Loxapine, inhalation powder, 10 mg
short | Loxapine, inhalation powder |
|
|